Intravascular Hemolysis and Complications During Extracorporeal Membrane Oxygenation
Hemolysis is an unavoidable side effect of current ECMO technology and there are no approved treatments or treatment guidelines for the neonatal population. Therefore, increased vigilance, recognition of the severity of the hemolytic process, and prompt management are essential to prevent severe endothelial injury leading to proinflammatory and prothrombotic events.
Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome
Severe patterns of COVID-19 ARDS are characterized by a thrombin burst and the consequent coagulation activation. Mechanisms of fibrinolysis regulation appear unbalanced toward fibrinolysis inhibition. This pattern ameliorates in survivors, whereas it worsens in nonsurvivors.
Heparin Concentration in Cell Salvage During Heparinization: A Pilot Study
Salvaged blood during cardiovascular surgery intervention does not contain enough heparin to influence activated clotting time.
Measuring and Monitoring Perioperative Patient Safety: A Basic Approach for Clinicians
Considering the potential for perioperative patient safety measurements to improve patient outcomes, the absence of a generally accepted measurement standard and manifold barriers to reporting, a pragmatic approach to locally measuring patient safety appears advisable.
Current Impact of Cardiopulmonary Bypass in Coronary Artery Bypass Grafting in São Paulo State
Currently in the REPLICCAR, reoperation for bleeding was the only outcome associated with the use of CPB in CABG.
Acute Type A Aortic Dissection During the COVID-19 Outbreak
We present a case of acute type A aortic dissection in a patient with COVID-19 to highlight the clinical implications of a true emergent procedure during the COVID-19 outbreak.
Comparison between the Effects of Bretschneider’s HTK Solution and Cold Blood Cardioplegia on Systemic Endothelial Functions in Patients who Undergo Coronary Artery Bypass Surgery: a Prospective Randomized and Controlled Trial
Cardiopulmonary bypass leads to endothelial dysfunction. Our results revealed that Bretschneider’s HTK solution causes less severe endothelial injury than cold blood cardioplegia.
A Randomized Controlled Trial Comparing Controlled Reoxygenation and Standard Cardiopulmonary Bypass in Paediatric Cardiac Surgery
Controlled reoxygenation (normoxic) CPB is safe but with no evidence of a clinical advantage over hyperoxic CPB.
Cytosorb® Hemoadsorption of Apixaban During Emergent Cardio-Pulmonary Bypass: A Case Report
Insertion of a CytoSorb® cartridge in the CPB was safe and associated with rapid correction of Apixaban-associated anticoagulation.
Comparison of Atrio-Femoral and Femoro-Atrial Venovenous Extracorporeal Membrane Oxygenation in Adult.
Atrio-femoral configuration in VV ECMO was associated with a higher maximum achieved ECMO flow, less fluid gain in first 3 days of ECMO and more successful awake ECMO.
Comparison of The Operative and Postoperative Effects of Del Nido and Blood Cardioplegia Solutions in Cardiopulmonary Bypass Surgery
Our goal was to compare the operative and postoperative effects of del Nido cardioplegia (DN group) and blood cardioplegia (BC group) performed in cardiac surgery.
Perioperative Applications of Therapeutic Plasma Exchange in Cardiac Surgery: A Narrative Review
The review is based on published literature and the authors’ institutional experience with perioperative TPE in cardiac surgical patients.